https://www.eurekalert.org/pub_releases/2020-10/uom-uom102120.php
News Release 21-Oct-2020
University of Minnesota
University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus - health care workers.
The pre-exposure prophylaxis trial results, which were published in Clinical Infectious Diseases, determined that taking 400mg of hydroxychloroquine once or twice weekly did not prevent the development of COVID-19 in health care workers better than the placebo.
•••••
No comments:
Post a Comment